These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34894317)

  • 21. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy.
    Haland TF; Almaas VM; Hasselberg NE; Saberniak J; Leren IS; Hopp E; Edvardsen T; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):613-21. PubMed ID: 26873460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy.
    Yang F; Wang L; Wang J; Pu L; Xu Y; Li W; Wan K; Yang D; Sun J; Han Y; Zhu Y; Chen Y
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):36. PubMed ID: 33761947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a rapid semi-automated method to assess left atrial longitudinal phasic strains on cine cardiovascular magnetic resonance imaging.
    Leng S; Tan RS; Zhao X; Allen JC; Koh AS; Zhong L
    J Cardiovasc Magn Reson; 2018 Nov; 20(1):71. PubMed ID: 30396356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
    Mentias A; Raeisi-Giglou P; Smedira NG; Feng K; Sato K; Wazni O; Kanj M; Flamm SD; Thamilarasan M; Popovic ZB; Lever HM; Desai MY
    J Am Coll Cardiol; 2018 Aug; 72(8):857-870. PubMed ID: 30115224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Dimensional regional and global strain abnormalities in hypertrophic cardiomyopathy.
    Satriano A; Heydari B; Guron N; Fenwick K; Cheung M; Mikami Y; Merchant N; Lydell CP; Howarth AG; Fine NM; White JA
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1913-1924. PubMed ID: 31144257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
    Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
    Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
    Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing right ventricular deformation in hypertrophic cardiomyopathy patients with preserved right ventricular ejection fraction: a 3.0-T cardiovascular magnetic resonance study.
    Li X; Shi K; Yang ZG; Guo YK; Huang S; Xia CC; He S; Li ZL; Li C; He Y
    Sci Rep; 2020 Feb; 10(1):1967. PubMed ID: 32029853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiographic predictors of myocardial fibrosis and apical hypertrophic cardiomyopathy.
    Tangwiwat C; Kaolawanich Y; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12612. PubMed ID: 30403441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
    Freitas P; Ferreira AM; Arteaga-Fernández E; de Oliveira Antunes M; Mesquita J; Abecasis J; Marques H; Saraiva C; Matos DN; Rodrigues R; Cardim N; Mady C; Rochitte CE
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):50. PubMed ID: 31412875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High ECG Risk-Scores Predict Late Gadolinium Enhancement on Magnetic Resonance Imaging in HCM in the Young.
    Österberg AW; Östman-Smith I; Jablonowski R; Carlsson M; Green H; Gunnarsson C; Liuba P; Fernlund E
    Pediatr Cardiol; 2021 Mar; 42(3):492-500. PubMed ID: 33515326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise echocardiography and cardiac magnetic resonance imaging to predict outcome in patients with hypertrophic cardiomyopathy.
    Peteiro J; Fernandez X; Bouzas-Mosquera A; Monserrat L; Méndez C; Rodriguez-Garcia E; Soler R; Couto D; Castro-Beiras A
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):423-32. PubMed ID: 25428944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
    Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
    J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.